πŸ“£ VC round data is live. Check it out!

Sedana Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sedana Medical and similar public comparables like Vivani Medical, Susmed, Zomedica, SomnoMed and more.

Sedana Medical Overview

About Sedana Medical

Sedana Medical AB is a Sweden-based medical technology company. It is a pioneer MedTech and pharmaceutical company focused on inhaled sedation to improve the patient’s life during and beyond sedation. The group's product range is Sedaconda ACD, Sedaconda, AnaConDa, FlurAbsorb, Gas Monitor, Adapters, and Accessories. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.


Founded

2005

HQ

Sweden

Employees

109

Financials (LTM)

Revenue: $22M
EBITDA: ($919K)

EV

$97M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Sedana Medical Financials

Sedana Medical reported last 12-month revenue of $22M and negative EBITDA of ($919K).

In the same LTM period, Sedana Medical generated ($919K) in EBITDA losses and had net loss of ($5M).

Revenue (LTM)


Sedana Medical P&L

In the most recent fiscal year, Sedana Medical reported revenue of $22M and EBITDA of ($1M).

Sedana Medical is unprofitable as of last fiscal year, with gross margin of 68%, EBITDA margin of (5%), and net margin of (28%).

See analyst estimates for Sedana Medical
LTMLast FY202320242025202620272028
Revenue$22M$22M$17M$19M$22M
Gross Profitβ€”$15M$12M$14M$15M
Gross Marginβ€”68%71%71%71%
EBITDA($919K)($1M)($4M)$1M($4M)
EBITDA Margin(4%)(5%)(22%)7%(17%)
EBIT Margin(15%)(16%)(43%)(28%)(16%)
Net Profit($5M)($6M)($6M)($1M)($6M)
Net Margin(23%)(28%)(39%)(6%)(30%)

Financial data powered by Morningstar, Inc.

Sedana Medical Stock Performance

Sedana Medical has current market cap of $105M, and enterprise value of $97M.

Market Cap Evolution


Sedana Medical's stock price is $1.06.

Sedana Medical share price decreased by 4.9% in the last 30 days, and by 18.5% in the last year.

Sedana Medical has an EPS (earnings per share) of $-0.06.

See more trading valuation data for Sedana Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$97M$105M-0.2%-4.9%9.9%-18.5%$-0.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Sedana Medical Valuation Multiples

Sedana Medical trades at 4.3x EV/Revenue multiple, and (105.5x) EV/EBITDA.

See NTM and 2027E valuation multiples for Sedana Medical

EV / Revenue (LTM)


Sedana Medical Financial Valuation Multiples

As of May 9, 2026, Sedana Medical has market cap of $105M and EV of $97M.

Sedana Medical has a P/E ratio of (20.0x).

LTMLast FY202320242025202620272028
EV/Revenue4.3x4.3x5.8x5.0x4.5x
EV/EBITDA(105.5x)(86.2x)(26.7x)67.1x(26.6x)
EV/EBIT(27.9x)(27.6x)(13.5x)(17.7x)(27.6x)
EV/Gross Profitβ€”6.3x8.3x7.1x6.3x
P/E(20.0x)(16.4x)(16.3x)(91.1x)(16.4x)
EV/FCF(12.8x)(12.0x)(4.3x)(4.8x)(12.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Sedana Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Sedana Medical Margins & Growth Rates

Sedana Medical decreased revenue by 1% and EBITDA by 52% in the last fiscal year.

In the most recent fiscal year, Sedana Medical reported gross margin of 68%, EBITDA margin of (5%), and net margin of (28%).

See estimated margins and future growth rates for Sedana Medical

Sedana Medical Margins

Last FY202420252026202720282029
Gross Margin68%71%71%β€”
EBITDA Margin(5%)7%(17%)(2%)
EBIT Margin(16%)(28%)(16%)(15%)
Net Margin(28%)(6%)(30%)(12%)
FCF Margin(36%)(104%)(38%)(22%)

Sedana Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(1%)16%12%4%
Gross Profit Growthβ€”16%13%β€”
EBITDA Growth(52%)(140%)(352%)(85%)
EBIT Growth(7%)(24%)(36%)(7%)
Net Profit Growth(58%)(82%)455%(58%)
FCF Growth(38%)(10%)(60%)(38%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Sedana Medical Operational KPIs

Sedana Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Sedana Medical's Rule of 40 is 1% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Sedana Medical's Rule of X is 6% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Sedana Medical
LTMLast FY202320242025202620272028
Rule of 405%1%β€”β€”β€”
Bessemer Rule of X18%6%β€”β€”β€”
Revenue per Employeeβ€”$0.2Mβ€”β€”β€”
Opex per Employeeβ€”$0.2Mβ€”β€”β€”
S&M Expenses to Revenueβ€”48%70%59%50%
G&A Expenses to Revenueβ€”26%31%29%27%
R&D Expenses to Revenueβ€”10%14%11%10%
Opex to Revenueβ€”84%114%99%88%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Sedana Medical Competitors

Sedana Medical competitors include Vivani Medical, Susmed, Zomedica, SomnoMed, Neuronetics, Fractyl Health, Fonar, AOTI, SDI Group and C-Rad.

Most Sedana Medical public comparables operate across Medical Devices, DeepTech, HealthTech and BioTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Vivani Medicalβ€”β€”(3.9x)β€”
Susmed23.4x15.6x(39.2x)β€”
Zomedica2.1x2.1x(3.3x)β€”
SomnoMed1.1x1.0x14.4x11.0x
Neuronetics1.3x1.2x(8.7x)(10.3x)
Fractyl Healthβ€”β€”(1.1x)(1.1x)
Fonar1.0xβ€”5.7xβ€”
AOTI1.5xβ€”13.0xβ€”

This data is available for Pro users. Sign up to see all Sedana Medical competitors and their valuation data.

Start Free Trial

Sedana Medical M&A Activity

Sedana Medical has acquired 1 company to date.

Last acquisition by Sedana Medical was on July 22nd 2024. Sedana Medical acquired Innovatif Cekal for $3M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Sedana Medical

Innovatif Cekal
Description
Innovatif Cekal is a French manufacturer producing precision components and assemblies for medical devices. It specializes in machining, surface treatments, and cleanroom assembly for implants, surgical instruments, and diagnostic equipment. Certified to ISO 13485 standards, the company supplies orthopedic, cardiovascular, and endoscopy sectors from its facility in Saint-Etienne. Innovatif Cekal exports to European medical OEMs emphasizing quality control and rapid prototyping capabilities.
HQ CountryMalaysia
HQ City
Shah Alam
Deal Date22 Jul 2024
Valuation$3M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Sedana Medical acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Sedana Medical

When was Sedana Medical founded?Sedana Medical was founded in 2005.
Where is Sedana Medical headquartered?Sedana Medical is headquartered in Sweden.
How many employees does Sedana Medical have?As of today, Sedana Medical has over 109 employees.
Who is the CEO of Sedana Medical?Sedana Medical's CEO is Johannes Doll.
Is Sedana Medical publicly listed?Yes, Sedana Medical is a public company listed on Nasdaq Stockholm.
What is the stock symbol of Sedana Medical?Sedana Medical trades under SEDANA ticker.
When did Sedana Medical go public?Sedana Medical went public in 2017.
Who are competitors of Sedana Medical?Sedana Medical main competitors include Vivani Medical, Susmed, Zomedica, SomnoMed, Neuronetics, Fractyl Health, Fonar, AOTI, SDI Group, C-Rad.
What is the current market cap of Sedana Medical?Sedana Medical's current market cap is $105M.
What is the current revenue of Sedana Medical?Sedana Medical's last 12 months revenue is $22M.
What is the current revenue growth of Sedana Medical?Sedana Medical revenue growth (NTM/LTM) is 9%.
What is the current EV/Revenue multiple of Sedana Medical?Current revenue multiple of Sedana Medical is 4.3x.
Is Sedana Medical profitable?No, Sedana Medical is not profitable.
What is the current EBITDA of Sedana Medical?Sedana Medical has negative EBITDA and is not profitable.
What is Sedana Medical's EBITDA margin?Sedana Medical's last 12 months EBITDA margin is (4%).
What is the current EV/EBITDA multiple of Sedana Medical?Current EBITDA multiple of Sedana Medical is (105.5x).
What is the current FCF of Sedana Medical?Sedana Medical's last 12 months FCF is ($8M).
What is Sedana Medical's FCF margin?Sedana Medical's last 12 months FCF margin is (34%).
What is the current EV/FCF multiple of Sedana Medical?Current FCF multiple of Sedana Medical is (12.8x).
How many companies Sedana Medical has acquired to date?As of May 2026, Sedana Medical has acquired 1 company.
What was the largest acquisition by Sedana Medical?$3M acquisition of Innovatif Cekal on 22nd July 2024 was the largest M&A Sedana Medical has done to date.
What companies Sedana Medical acquired?Sedana Medical acquired Innovatif Cekal.
In how many companies Sedana Medical has invested to date?Sedana Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Sedana Medical

Lists including Sedana Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial